Hypoxia induces dysregulation of local renin-angiotensin system in mouse Lewis lung carcinoma cells

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 10562-10573

  Fan, L ^a   Feng, Y ^a   Wan, H Y ^a   Ni, L ^a   Qian, Y R ^a   Guo, Y ^a   Xiang, Y ^a   Li, Q Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hypoxia; Lewis lung carcinoma cell; Renin angiotensin system; Vascular endothelial growth factor A

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CAPTOPRIL; COBALT CHLORIDE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; VASCULOTROPIN A; ACE PROTEIN, HUMAN; ANGIOTENSIN CONVERTING ENZYME 2;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HYPOXIA; INCUBATOR; LEWIS LUNG CARCINOMA CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TUMOR CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARCINOMA, LEWIS LUNG; GENE EXPRESSION REGULATION; GENETICS; HUMAN;

ANGIOTENSIN II; ANIMALS; CARCINOMA, LEWIS LUNG; CELL HYPOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM;

EID: 84917706575     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.December.12.19     Document Type: Article

References (29)

1. Attoub S, Gaben AM, Al-Salam S, Al Sultan MA, et al. (2008). Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann. N. Y. Acad. Sci. 65-72.
2. Egami K, Murohara T, Shimada T, Sasaki K, et al. (2003). Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J. Clin. Invest. 112: 67-75.
3. Feng Y, Wan H, Liu J, Zhang R, et al. (2010). The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncol. Rep. 23: 941-948.
4. Fleming I, Kohlstedt K and Busse R (2005). New fACEs to the renin-angiotensin system. Physiology 20: 91-95.
5. Fujita M, Hayashi I, Yamashina S, Itoman M, et al. (2002). Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem. Biophys. Res. Commun. 294: 441-447.
6. Fujita M, Hayashi I, Yamashina S, Fukamizu A, et al. (2005). Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26: 271-279.
7. Fung ML, Lam SY, Dong X, Chen Y, et al. (2002). Postnatal hypoxemia increases angiotensin II sensitivity and up-regulates AT1a angiotensin receptors in rat carotid body chemoreceptors. J. Endocrinol. 173: 305-313.
8. Fyhrquist F and Saijonmaa O (2008). Renin-angiotensin system revisited. J. Intern. Med. 264: 224-236.
9. George AJ, Thomas WG and Hannan RD (2010). The renin-angiotensin system and cancer: old dog, new tricks. Nat. Rev. Cancer 10: 745-759.
10. Gallagher PE and Tallant EA (2004). Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25: 2045-2052.
11. Gallagher PE, Cook K, Soto-Pantoja D, Menon J, et al. (2011). Angiotensin peptides and lung cancer. Curr. Cancer Drug Targets 11: 394-404.
12. Imai N, Hashimoto T, Kihara M, Yoshida S, et al. (2007). Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab. Invest. 87: 189-198.
13. Iwai M and Horiuchi M. (2009). Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res.32: 533-536.
14. Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90.
15. Kanehira T, Tani T, Takagi T, Nakano Y, et al. (2005). Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation. Cancer Res. 65: 7660-7665.
16. Kinoshita J, Fushida S, Harada S, Yagi Y, et al. (2009). Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. Int. J. Oncol. 34: 1573-1582.
17. Koka V, Huang XR, Chung AC, Wang W, et al. (2008). Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am. J. Pathol. 172: 1174-1183.
18. Mao C, Hou J, Ge J, Hu Y, et al. (2010). Changes of renal AT1/AT2 receptors and structures in ovine fetuses following exposure to long-term hypoxia. Am. J. Nephrol. 31: 141-150.
19. Neo JH, Ager EI, Angus PW, Zhu J, et al. (2010). Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. BMC Cancer 10: 134.
20. Ni L, Feng Y, Wan H, Ma Q, et al. (2012). Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol. Rep. 27: 783-790.
21. Pickel L, Matsuzuka T, Doi C, Ayuzawa R, et al. (2010). Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biol. Ther. 9: 4.
22. Rocken C, Rohl FW, Diebler E, Lendeckel U, et al. (2007). The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol. Biomarkers Prev. 16: 1206-1212.
23. Shibata K, Makino I, Shibaguchi H, Niwa M, et al. (1997). Up-regulation of angiotensin type 2 receptor mRNA by angiotensin II in rat cortical cells. Biochem. Biophys. Res. Commun. 239: 633-637.
24. Soto-Pantoja DR, Menon J, Gallagher PE and Tallant EA (2009). Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol. Cancer Ther. 8: 1676-1683.
25. Suganuma T, Ino K, Shibata K, Kajiyama H, et al. (2005). Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin. Cancer Res. 11: 2686-2694.
26. Tanaka M, Tsuchida S, Imai T, Fujii N, et al. (1999). Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem. Biophys. Res. Commun. 258: 194-198.
27. van Kats JP, Danser AH, van Meegen JR, Sassen LM, et al. (1998). Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 98: 73-81.
28. Volpe M, Musumeci B, De Paolis P, Savoia C, et al. (2003). Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J. Hypertens. 21: 1429-1443.
29. Zhang R, Wu Y, Zhao M, Liu C, et al. (2009). Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: 10.